Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Britannin
Cat. No.:
OB0225LY-0393
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Britannin is a sesquiterpene lactone that inhibits proliferation and induces apoptosis in human breast cancer cells.
Synonym:
33627-28-0; [(3aS,5R,5aS,6S,8S,8aS,9S,9aR)-9-Acetyloxy-8-hydroxy-5,8a-dimethyl-1-methylidene-2-oxo-4,5,5a,6,7,8,9,9a-octahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate; (3aR,4S,4aS,5S,7S,7aS,8R,9aS)-4-(Acetyloxy)-5-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3aH-azuleno[6,5-b]furan-7-yl acetate
CAS No.:
33627-28-0
Compound CID:
14466541
Formula:
C19H26O7
Formula Weight:
366.41
Specification
Relative Density:
1.25 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Britannin can be used to study the role of plant-derived compounds in anti-inflammatory responses or to explore their potential biological activities in pharmacological studies.
Library Information
Targets:
Serine/Threonine kinases
Receptors:
AMPK
Pathways:
Chromatin/Epigenetic; Apoptosis; PI3K/Akt/mTOR signaling; Autophagy
Plate Number:
AOCL-6
Plate Location:
a8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 122.81 mM
